Half-year report · Q2
5199.TEDINET S100UO35
Period2024-04-01 → 2024-09-30
Filed2024-11-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥3.6bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥7.5bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥3.9bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | ¥135m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | ¥247m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | ¥120m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥382m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥240m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥98m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥238m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥58m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥290m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥174m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥58m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | ¥174m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥11.2bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥11.3bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥11.4bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.4bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥7.5bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.8bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥3.9bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.7bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.9bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.7bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.5bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.4bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.4bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥201m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥211m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥153m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥53m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥123m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥53m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥90m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥347m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥283m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥45.82 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥228.42 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥137 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 34.1% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.1% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.6% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥227m |
| jpcrp040300-q2r_E01109-000Medical Equipmentreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.4bn |
| jpcrp040300-q2r_E01109-000Medical Equipmentreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.4bn |
| jpcrp040300-q2r_E01109-000Medical Equipmentreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥70m |
| jpcrp040300-q2r_E01109-000Precision Equipmentreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.9bn |
| jpcrp040300-q2r_E01109-000Precision Equipmentreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.9bn |
| jpcrp040300-q2r_E01109-000Precision Equipmentreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥309m |
| jpcrp040300-q2r_E01109-000SPreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥224m |
| jpcrp040300-q2r_E01109-000SPreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥224m |
| jpcrp040300-q2r_E01109-000SPreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥5m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥3.6bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥3.6bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥362m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥239m |
| jpcrp040300-q2r_E01109-000Medical Equipmentreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E01109-000Medical Equipmentreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E01109-000Medical Equipmentreportable segment | segment profit | 2023-04-01 → 2023-09-30 | −¥2m |
| jpcrp040300-q2r_E01109-000Precision Equipmentreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥2.1bn |
| jpcrp040300-q2r_E01109-000Precision Equipmentreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥2.1bn |
| jpcrp040300-q2r_E01109-000Precision Equipmentreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥459m |
| jpcrp040300-q2r_E01109-000SPreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥397m |
| jpcrp040300-q2r_E01109-000SPreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥397m |
| jpcrp040300-q2r_E01109-000SPreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥13m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥3.9bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥3.9bn |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥486m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 511
| Item | Context | Value | Unit |
|---|---|---|---|
| Net cash provided by used in operating activities | Prior1YTDDuration | 152780000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | 200653000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1YTDDuration | -46987000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYTDDuration | -34208000 | JPY |
| Purchase of intangible assets inv cf | Prior1YTDDuration | -2834000 | JPY |
| Purchase of intangible assets inv cf | CurrentYTDDuration | -792000 | JPY |
| Purchase of investment securities inv cf | Prior1YTDDuration | -3059000 | JPY |
| Purchase of investment securities inv cf | CurrentYTDDuration | -3187000 | JPY |
| Proceeds from sales of investment securities inv cf | Prior1YTDDuration | － | JPY |
| Proceeds from sales of investment securities inv cf | CurrentYTDDuration | 90814000 | JPY |
| Other net inv cf | Prior1YTDDuration | -145000 | JPY |
| Other net inv cf | CurrentYTDDuration | -70000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | -53026000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | 52555000 | JPY |
| Net increase decrease in short term loans payable fin cf | Prior1YTDDuration | － | JPY |
| Net increase decrease in short term loans payable fin cf | CurrentYTDDuration | 210000000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YTDDuration | -170666000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | -193166000 | JPY |
| Payments of commission for syndicate loan fin cf | Prior1YTDDuration | -1592000 | JPY |
| Payments of commission for syndicate loan fin cf | CurrentYTDDuration | -1571000 | JPY |
| Repayments of lease obligations fin cf | Prior1YTDDuration | -47435000 | JPY |
| Repayments of lease obligations fin cf | CurrentYTDDuration | -41691000 | JPY |
| Purchase of treasury stock fin cf | Prior1YTDDuration | -15000 | JPY |
| Purchase of treasury stock fin cf | CurrentYTDDuration | -337000 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -62850000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -63643000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -282560000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -90410000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | 12838000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | 7147000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | -169967000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | 169946000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 1608304000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 1365428000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 1438337000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 1535375000 | JPY |
| Salaries and bonuses sga | Prior1YTDDuration | 202502000 | JPY |
| Salaries and bonuses sga | CurrentYTDDuration | 195761000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 50218000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 49725000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 10119000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 10514000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E01109-000MedicalEquipmentReportableSegmentsMember | 1222462000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E01109-000PrecisionEquipmentReportableSegmentsMember | 2128571000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E01109-000SPReportableSegmentsMember | 396609000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E01109-000FoodContainerMember | 118625000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 3866268000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 3866268000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E01109-000MedicalEquipmentReportableSegmentsMember | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |